Supplemental material
Hematology
Volume 24, 2019 - Issue 1
Related Research Data
Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma
Source:
Informa UK Limited
Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
Source:
American Society of Clinical Oncology (ASCO)
Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?
Source:
Springer Nature
Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)
Source:
Springer Nature
Outcomes and Effect of Radiotherapy in Patients With Stage I or II Diffuse Large B-Cell Lymphoma: A Surveillance, Epidemiology, and End Results Analysis
Source:
Elsevier BV
ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma
Source:
New England Journal of Medicine (NEJM/MMS)
Chemotherapy Alone for Localized Diffuse Large B-Cell Lymphoma
Source:
Ovid Technologies (Wolters Kluwer Health)
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States
Source:
Wiley-Blackwell
The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas
Source:
American Society of Hematology
Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement
Source:
American Society of Clinical Oncology (ASCO)
A Review
Source:
American Medical Association (AMA)
The Role of Radiotherapy in Early-stage Primary Diffuse Large B-Cell Lymphoma of the Waldeyer Ring
Source:
Ovid Technologies (Wolters Kluwer Health)
Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group
Source:
Elsevier BV
Adjuvant radiotherapy and chemotherapy in early-stage diffuse large B cell lymphoma of head and neck with extranodal involvement
Source:
Taylor & Francis
Role of Radiotherapy to Bulky Disease in Elderly Patients With Aggressive B-Cell Lymphoma
Source:
American Society of Clinical Oncology (ASCO)
Combined-Modality Therapy for Early-Stage Diffuse Large B-Cell Lymphoma: Knowing When to Quit
Source:
American Society of Clinical Oncology (ASCO)
Challenges of Guarantee-Time Bias
Source:
American Society of Clinical Oncology (ASCO)
Benefit of Consolidative Radiation Therapy in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP Chemotherapy
Source:
American Society of Clinical Oncology (ASCO)
Adjuvant radiotherapy and chemotherapy in early-stage diffuse large B cell lymphoma of head and neck with extranodal involvement
Source:
Taylor & Francis
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma
Source:
Massachusetts Medical Society
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
Source:
Massachusetts Medical Society
Older patients with early-stage diffuse large B-cell lymphoma: the role of consolidation radiotherapy after chemoimmunotherapy
Source:
Informa UK Limited
Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2
Source:
American Society of Hematology
Extranodal lymphomas of the head and neck
Source:
Elsevier BV
Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis
Source:
Elsevier BV
Treatment outcome of diffuse large B-cell lymphoma involving the head and neck
Source:
Ovid Technologies (Wolters Kluwer Health)
Central nervous system involvement following diagnosis of non-Hodgkin’s lymphoma: a risk model
Source:
Elsevier BV
Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era.
Source:
American Society of Clinical Oncology (ASCO)
Linking provided by
